v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (16,581,558) $ (15,289,167)
Adjustments to reconcile net loss to net cash (used in) operating activities    
Depreciation and amortization 80,881 313,019
Stock based compensation - stock option grants 2,957,559 2,955,933
Issuance of common stock for services 277,011 0
Gain on debt settlement 0 (50,000)
Loss on disposal of assets 0 549,431
Loss on debt extinguishment 0 506,865
Amortization of operating lease right-of-use asset 189,286 142,840
Amortization of debt issuance costs 830,948 0
Interest expense for extension of notes and warrants 594,761 349,721
Changes in operating assets and liabilities:    
Other long-term assets (133,408) (1,999)
Operating lease right-of-use liability (178,408) (147,719)
Accounts payable - trade and accrued expenses (866,422) 317,085
NET CASH (USED IN) OPERATING ACTIVITIES (12,829,350) (10,353,991)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of research and development equipment (66,352) (80,797)
NET CASH (USED IN) INVESTING ACTIVITIES: (66,352) (80,797)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from debt offering 3,764,129 0
Repayment of note payable (720,000) 0
Proceeds from issuance of common stock offering, net 5,193,262 5,472,791
Payments of debt offering (262,450) 0
Proceeds from issuance of common stock for warrant exercise 7,800 387,334
Proceeds from issuance of common stock for stock options exercise 0 4,687
NET CASH PROVIDED BY FINANCING ACTIVITIES 7,982,741 5,864,812
NET (DECREASE) IN CASH AND CASH EQUIVALENTS (4,912,961) (4,569,976)
CASH AND CASH EQUIVALENTS, beginning of period 8,023,716 12,593,692
CASH AND CASH EQUIVALENTS, end of period 3,110,755 8,023,716
Supplemental disclosures of cash flow information:    
Interest paid 241,000 140,000
Taxes paid 0 0
Supplemental disclosure of non-cash financing activity:    
Deemed dividends on Series C and D Preferred Stock 313,536 3,526,653
Common stock dividends on Series D Preferred Stock 0 1,627,230
Warrants issued for debt offering 2,110,731 0
Common stock issued for debt payment 240,000 0
Issuance costs from common stock offering $ 670,149 $ 1,527,209

Source

10-K PDF
XBRL